Descripción

Subgroup analysis of gut microbiota composition across IBS subtypes from the multicenter amplicon sequencing study. The data explore whether specific microbial signatures distinguish different IBS clinical presentations.

Figure 11

Chart

Source Paper

Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.

Journal of translational medicine (2023)

PMID: 36774467

DOI: 10.1186/s12967-023-03953-7

Cite This Figure

![Figure 11: Subgroup analysis of gut microbiota composition across IBS subtypes from the multicenter amplicon sequencing study. The data explore whether specific microbial signatures distinguish different IBS clinical presentations.]()

> Source: Han Chen et al. "Alternation of the gut microbiota in irritable bowel syndrome: an integrated ana." *Journal of translational medicine*, 2023. PMID: [36774467](https://pubmed.ncbi.nlm.nih.gov/36774467/)

<figure>
  <img src="" alt="Subgroup analysis of gut microbiota composition across IBS subtypes from the multicenter amplicon sequencing study. The data explore whether specific microbial signatures distinguish different IBS clinical presentations." />
  <figcaption>Figure 11. Subgroup analysis of gut microbiota composition across IBS subtypes from the multicenter amplicon sequencing study. The data explore whether specific microbial signatures distinguish different IBS clinical presentations.<br>  Source: Han Chen et al. "Alternation of the gut microbiota in irritable bowel syndrome: an integrated ana." <em>Journal of translational medicine</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36774467/">36774467</a></figcaption>
</figure>

Evidencia relacionada

Bifidobacterium longum para Irritable Bowel Syndrome (IBS)

Calificación B · 4 estudios

Bifidobacterium breve para Irritable Bowel Syndrome (IBS)

Calificación D · 2 estudios